|
Hydroxychloroquine Clinical Trials
10 actively recruiting trials across 6 locations
No change since June 2026
Also known as: HCQ, Plaquenil
Pipeline
Phase 2: 5Phase 3: 2Phase 4: 1Phase 1/2: 1Phase 2/3: 1
Top Sponsors
- NYU Langone Health2
- VA Office of Research and Development1
- University of Nebraska1
- Tongji Hospital1
- Qilu Hospital of Shandong University1
Other3 trials
Philadelphia, Pennsylvania2 trials
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
Abramson Cancer Center of the University of Pennsylvania
Phase 2
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Phase 1/2
Los Angeles, California1 trial
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
University of California, Los Angeles
Phase 3
Chicago, Illinois1 trial
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
New York, New York1 trial
Charleston, South Carolina1 trial
Autophagy Maintenance (AUTOMAIN)
Medical University of South Carolina
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.